HealthEnabled, Washington, DC, United States.
Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States.
J Med Internet Res. 2024 Oct 11;26:e52792. doi: 10.2196/52792.
The Zindagi Mehfooz (safe life; ZM) electronic immunization registry (EIR) is a comprehensive suite of digital health interventions that aims to improve equitable access, timeliness, and coverage of child immunizations through a smartphone-based app for vaccinators, web-based dashboards for supervisors and managers, text message alerts and reminders for caregivers, and a call center. It has been implemented at scale in Sindh Province, Pakistan.
This study aimed to present findings from an evaluation of the ZM-EIR suite of digital health interventions in order to improve data availability and use as a contribution, among other immunization program interventions, to enhanced immunization outcomes for children aged 12-23 months in Sindh Province.
The mixed methods study included (1) analysis of ZM-EIR system data to identify high-, moderate-, and low-adoption and compliance sites; (2) in-depth interviews with caregivers, vaccinators, supervisors, and managers in the Expanded Program for Immunization (EPI); and (3) pre-post outcome evaluation using vaccine coverage from the Multiple Indicator Cluster Surveys (MICS) 2014 and 2018-2019. Key outcomes of interest were improved data availability, use and contribution to immunization outcomes, including receipt of individual antigens (Bacillus Calmette-Guérin [BCG], pentavalent [Penta] 1-3, measles), full immunization (all antigens), and zero-dose children defined as children aged 6-23 months who have not received the first dosage of the diphtheria-pertussis-tetanus 1/Penta vaccine.
By registering newborns, providing alerts and reminders, and tracking their immunization completion, the ZM-EIR improved data availability and use in the EPI. The ZM-EIR was well received by EPI administrators, supervisors, vaccinators, and caregivers. The key benefit highlighted by ZM-EIR users was a list of children who missed scheduled vaccines (defaulters). Through greater availability and use of data, the ZM-EIR implementation, as part of a broader package of immunization program-strengthening activities in Sindh Province, may have contributed to an increase in immunization coverage and timeliness for BCG vaccinations and a decrease in zero-dose children in 2018-2019 from 2014. Additional findings from the study included the dual burden of reporting on paper and gender-related considerations of female caregivers not wanting to provide their phone numbers to male vaccinators, creating barriers to greater uptake of the ZM-EIR.
The ZM-EIR is a promising technology platform that has increased the availability and use of immunization data, which may have contributed, along with other intensive immunization program interventions, to improvements in immunization outcomes through systematic registration of children, alerts and reminders, and increased use of data for planning and monitoring by the EPI.
ISRCTN Registry ISRCTN23078223; https://doi.org/10.1186/ISRCTN23078223.
Zindagi Mehfooz(安全生活;ZM)电子免疫登记册(EIR)是一套综合的数字健康干预措施,旨在通过为疫苗接种者提供基于智能手机的应用程序、为监督者和管理人员提供基于网络的仪表板、为照顾者提供短信提醒和提醒、以及呼叫中心,改善儿童免疫接种的公平获取、及时性和覆盖率。它已在巴基斯坦信德省大规模实施。
本研究旨在介绍 ZM-EIR 数字健康干预措施套件的评估结果,以便提高数据可用性和使用效率,作为对信德省 12-23 个月儿童免疫接种结果的贡献,除其他免疫规划干预措施外。
这项混合方法研究包括:(1)分析 ZM-EIR 系统数据,以确定高、中、低采用率和合规性站点;(2)对扩大免疫规划(EPI)中的照顾者、疫苗接种者、监督员和管理人员进行深入访谈;(3)使用 2014 年和 2018-2019 年多指标类集调查(MICS)的疫苗覆盖率进行前后结果评估。感兴趣的主要结果是改善数据可用性、使用效率以及对免疫结果的贡献,包括接受个体抗原(卡介苗[BCG]、五价疫苗 1-3、麻疹)、完全免疫(所有抗原)和零剂量儿童(定义为 6-23 个月未接种白喉、百日咳、破伤风 1/Penta 疫苗第一剂的儿童)。
ZM-EIR 通过登记新生儿、提供提醒和跟踪他们的免疫接种完成情况,提高了 EPI 中的数据可用性和使用效率。ZM-EIR 受到 EPI 管理人员、监督者、疫苗接种者和照顾者的欢迎。ZM-EIR 用户强调的主要好处是列出了错过预定疫苗接种的儿童(漏种者)。通过更大程度地利用和使用数据,ZM-EIR 的实施,作为信德省加强免疫规划的一整套综合活动的一部分,可能有助于增加 BCG 疫苗接种的覆盖率和及时性,并减少 2018-2019 年零剂量儿童的数量,与 2014 年相比。该研究的其他发现包括,在纸质报告方面存在双重负担,以及女性照顾者出于性别考虑不愿向男疫苗接种者提供电话号码,这为更大程度地采用 ZM-EIR 带来了障碍。
ZM-EIR 是一个有前途的技术平台,它增加了免疫数据的可用性和使用效率,这可能有助于通过系统登记儿童、提醒和提醒、以及增加数据在规划和监测方面的使用,与其他强化免疫规划干预措施一起,改善免疫接种结果。
ISRCTN 注册表 ISRCTN23078223;https://doi.org/10.1186/ISRCTN23078223。